File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: ACR appropriateness criteria® radiation therapy for small-cell lung cancer

TitleACR appropriateness criteria® radiation therapy for small-cell lung cancer
Authors
Keywordsappropriateness criteria
small cell lung cancer
radiation therapy
Issue Date2013
Citation
American Journal of Clinical Oncology: Cancer Clinical Trials, 2013, v. 36, n. 2, p. 206-213 How to Cite?
AbstractThe current standard of care for small cell lung cancer is combined-modality therapy, including the use of chemotherapy, surgery (in selected cases of limited stage of disease), and radiation therapy. This review will focus on the role, dose fractionation, technology and timing of thoracic radiation, and the role and dose regimen of prophylactic cranial irradiation for both limited and extensive stage of diseases. Consensus recommendation from experts is summarized in the tables for 2 typical case scenarios. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. Copyright © 2012 by Lippincott Williams &Wilkins.
Persistent Identifierhttp://hdl.handle.net/10722/266959
ISSN
2021 Impact Factor: 2.787
2020 SCImago Journal Rankings: 0.896
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorKong, Feng Ming-
dc.contributor.authorLally, Brian E.-
dc.contributor.authorChang, Joe Yujiao-
dc.contributor.authorChetty, Indrin J.-
dc.contributor.authorDecker, Roy H.-
dc.contributor.authorGinsburg, Mark E.-
dc.contributor.authorKestin, Larry L.-
dc.contributor.authorLanger, Corey J.-
dc.contributor.authorMovsas, Benjamin-
dc.contributor.authorVidetic, Gregory M.M.-
dc.contributor.authorWillers, Henning-
dc.contributor.authorRosenzweig, Kenneth E.-
dc.date.accessioned2019-01-31T07:20:06Z-
dc.date.available2019-01-31T07:20:06Z-
dc.date.issued2013-
dc.identifier.citationAmerican Journal of Clinical Oncology: Cancer Clinical Trials, 2013, v. 36, n. 2, p. 206-213-
dc.identifier.issn0277-3732-
dc.identifier.urihttp://hdl.handle.net/10722/266959-
dc.description.abstractThe current standard of care for small cell lung cancer is combined-modality therapy, including the use of chemotherapy, surgery (in selected cases of limited stage of disease), and radiation therapy. This review will focus on the role, dose fractionation, technology and timing of thoracic radiation, and the role and dose regimen of prophylactic cranial irradiation for both limited and extensive stage of diseases. Consensus recommendation from experts is summarized in the tables for 2 typical case scenarios. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. Copyright © 2012 by Lippincott Williams &Wilkins.-
dc.languageeng-
dc.relation.ispartofAmerican Journal of Clinical Oncology: Cancer Clinical Trials-
dc.subjectappropriateness criteria-
dc.subjectsmall cell lung cancer-
dc.subjectradiation therapy-
dc.titleACR appropriateness criteria® radiation therapy for small-cell lung cancer-
dc.typeArticle-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1097/COC.0b013e31827e5523-
dc.identifier.pmid23511336-
dc.identifier.scopuseid_2-s2.0-84876110620-
dc.identifier.volume36-
dc.identifier.issue2-
dc.identifier.spage206-
dc.identifier.epage213-
dc.identifier.eissn1537-453X-
dc.identifier.isiWOS:000316740100018-
dc.identifier.issnl0277-3732-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats